MetGen is a Finnish company active in development and production of biopharmaceuticals and industrial enzymes. MetGen solution is to generate novel biocatalysts replacing traditional chemical processes.
This will:
Reduce production costs
Reduce organic waste
Offer new chemicals via biotransformation
MetGen's know-how can be applied to rapidly evolve the most efficient enzyme or microbial strain for biocatalytic or fermentation processes in pharma, chemical and pulp & paper industry.
The company has completed its first round of investments and raised an undisclosed amount for establishing of operations according the development plan.
You are welcome to join our company for the second round of investments.
Please contact us for details.